• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素35可能导致原发性免疫性血小板减少症患者免疫自耐受性丧失。

Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia.

作者信息

Sun Tiantian, Zhang Donglei, Yang Yanhui, Zhang Xian, Lv Cuicui, Fu Rongfeng, Lv Mingen, Liu Wenjie, Chen Yunfei, Liu Wei, Huang Yueting, Xue Feng, Liu Xiaofan, Zhang Lei, Li Huiyuan, Yang Renchi

机构信息

State Key Laboratory of Experimental Haematology, Institute of Haematology and Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

出版信息

Br J Haematol. 2015 Apr;169(2):278-85. doi: 10.1111/bjh.13292. Epub 2015 Jan 29.

DOI:10.1111/bjh.13292
PMID:25640666
Abstract

Primary immune thrombocytopenia (ITP) is an autoimmune disorder. Interleukin-35 (IL35) can suppress T cell proliferation and elicit the development of inducible regulatory T cells (Tregs). Previous studies have shown decreased plasma IL35 levels and dysfunctional T cells in patients with ITP. In this study, we determined whether decreased IL35 levels correlate with T cell dysfunction in ITP patients. Plasma IL35 levels were found to be lower in ITP patients than in healthy controls, were positively correlated with platelet levels and the percentage of peripheral circulating Tregs, and negatively correlated with the levels of T helper-1 cells in ITP patients. We also evaluated the effects of IL35 on cytokines contributing to T cell proliferation. IL35 promoted the secretion of interleukin 10 (IL10) and transforming growth factor-β1 but reduced the levels of interferon-γ and IL17A (also termed IL17). Moreover, IL35 inhibited the proliferation of CD4+ and CD8+ T cells but induced the differentiation and proliferation of Tregs in ITP. In summary, IL35 appears to contribute to the loss of immunological self-tolerance in ITP patients by modulating T cells and immunoregulatory cytokines.

摘要

原发性免疫性血小板减少症(ITP)是一种自身免疫性疾病。白细胞介素-35(IL35)可抑制T细胞增殖并诱导诱导性调节性T细胞(Tregs)的发育。先前的研究表明,ITP患者血浆IL35水平降低且T细胞功能异常。在本研究中,我们确定了IL35水平降低是否与ITP患者的T细胞功能障碍相关。结果发现,ITP患者的血浆IL35水平低于健康对照,与血小板水平和外周循环Tregs百分比呈正相关,与ITP患者辅助性T1细胞水平呈负相关。我们还评估了IL35对促成T细胞增殖的细胞因子的影响。IL35促进白细胞介素10(IL10)和转化生长因子-β1的分泌,但降低干扰素-γ和IL17A(也称为IL17)的水平。此外,IL35抑制ITP中CD4 +和CD8 + T细胞的增殖,但诱导Tregs的分化和增殖。总之,IL35似乎通过调节T细胞和免疫调节细胞因子导致ITP患者免疫自我耐受的丧失。

相似文献

1
Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia.白细胞介素35可能导致原发性免疫性血小板减少症患者免疫自耐受性丧失。
Br J Haematol. 2015 Apr;169(2):278-85. doi: 10.1111/bjh.13292. Epub 2015 Jan 29.
2
Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.在免疫性血小板减少症中,IL-17A和IL-21的中和作用通过辅助性T细胞17相关信号通路调节调节性T细胞/辅助性T细胞17失衡。
Expert Opin Ther Targets. 2015 Jun;19(6):723-32. doi: 10.1517/14728222.2015.1016499.
3
Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia.原发性免疫性血小板减少症患者单核细胞 TLR4 表达降低可能导致调节性 T 细胞异常。
Autoimmunity. 2017 Aug;50(5):283-292. doi: 10.1080/08916934.2017.1309034. Epub 2017 Apr 17.
4
Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.免疫性血小板减少性紫癜患者CD4⁺CD25⁺FOXP3⁺调节性T细胞的频率和功能改变
Iran J Allergy Asthma Immunol. 2014 Apr;13(2):85-92.
5
Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.特发性血小板减少性紫癜患者中滤泡辅助性T细胞的变化
Int J Biol Sci. 2015 Jan 5;11(2):220-9. doi: 10.7150/ijbs.10178. eCollection 2015.
6
Involvement of levels of Toll like receptor-4 in monocytes, CD4+ T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura.Toll 样受体 4 水平在免疫性血小板减少性紫癜患者单核细胞、CD4+ T 淋巴细胞亚群及细胞因子中的作用。
Thromb Res. 2013 Aug;132(2):196-201. doi: 10.1016/j.thromres.2013.04.025. Epub 2013 Jul 2.
7
Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.CD4+CD25+调节性T细胞和转化生长因子-β1在儿童免疫性血小板减少性紫癜中的功能作用
Egypt J Immunol. 2006;13(1):173-87.
8
Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia.原发性免疫性血小板减少症患者中产生白细胞介素-17的CD4 + T淋巴细胞增多。
Blood Coagul Fibrinolysis. 2016 Apr;27(3):301-7. doi: 10.1097/MBC.0000000000000423.
9
Profile of Th17 cytokines (IL-17, TGF-beta, IL-6) and Th1 cytokine (IFN-gamma) in patients with immune thrombocytopenic purpura.免疫性血小板减少性紫癜患者中Th17细胞因子(白细胞介素-17、转化生长因子-β、白细胞介素-6)和Th1细胞因子(干扰素-γ)的概况
Ann Hematol. 2008 Nov;87(11):899-904. doi: 10.1007/s00277-008-0535-3. Epub 2008 Jul 4.
10
High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.大剂量地塞米松或全反式维 A 酸可使免疫性血小板减少症中巨噬细胞向 M2 型极化的失衡恢复平衡。
J Thromb Haemost. 2017 Sep;15(9):1845-1858. doi: 10.1111/jth.13767. Epub 2017 Aug 5.

引用本文的文献

1
Decreased Expression of IL-35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia.IL-35 及其受体表达降低导致免疫性血小板减少症发病机制中的巨核细胞生成受损。
Adv Sci (Weinh). 2024 Mar;11(12):e2305798. doi: 10.1002/advs.202305798. Epub 2024 Jan 15.
2
Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.免疫性血小板减少性紫癜:一种出血性与血栓性疾病——对病理生理机制的最新认识。
Medicina (Kaunas). 2022 Feb 1;58(2):211. doi: 10.3390/medicina58020211.
3
Increased expression of interleukin-17 is associated with macrophages in chronic immune thrombocytopenia.
白细胞介素-17表达增加与慢性免疫性血小板减少症中的巨噬细胞有关。
Int J Clin Exp Pathol. 2018 May 1;11(5):2419-2429. eCollection 2018.
4
Pancreatic cancer-associated inflammation drives dynamic regulation of p35 and Ebi3.胰腺癌相关炎症驱动p35和Ebi3的动态调节。
Cytokine. 2020 Jan;125:154817. doi: 10.1016/j.cyto.2019.154817. Epub 2019 Aug 28.
5
Research Progress on Chinese Medicine Immunomodulatory Intervention for Chronic Primary Immune Thrombocytopenia: Targeting Cellular Immunity.中药免疫调节干预慢性原发性免疫性血小板减少症的研究进展:针对细胞免疫。
Chin J Integr Med. 2019 Jul;25(7):483-489. doi: 10.1007/s11655-019-3031-9. Epub 2019 Jul 5.
6
High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia.大剂量地塞米松改变成人免疫性血小板减少症中白细胞介素-16 水平的升高。
Front Immunol. 2019 Mar 18;10:451. doi: 10.3389/fimmu.2019.00451. eCollection 2019.
7
CCR6 defines a subset of activated memory T cells of Th17 potential in immune thrombocytopenia.CCR6 定义了免疫性血小板减少症中 Th17 潜能激活记忆 T 细胞的一个亚群。
Clin Exp Immunol. 2019 Mar;195(3):345-357. doi: 10.1111/cei.13233. Epub 2018 Nov 25.
8
Interleukin 35 induced Th2 and Tregs bias under normal conditions in mice.在正常条件下,白细胞介素35在小鼠体内诱导Th2和调节性T细胞偏向。
PeerJ. 2018 Sep 21;6:e5638. doi: 10.7717/peerj.5638. eCollection 2018.
9
Interleukin-27: a novel biomarker in predicting bacterial infection among the critically ill.白细胞介素-27:危重症患者细菌感染预测中的一种新型生物标志物。
Crit Care. 2015 Oct 30;19:378. doi: 10.1186/s13054-015-1095-2.
10
Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners.调节性T细胞介导的抗炎作用以间接和直接方式促进成功的组织修复。
Front Pharmacol. 2015 Sep 2;6:184. doi: 10.3389/fphar.2015.00184. eCollection 2015.